相关实验视频
Updated: Jan 10, 2026

06:34
The Caco-2 Cell Bioassay for Measurement of Food Iron Bioavailability
Published on: April 28, 2022
5.5K
驴皮凝水解剂的稳定性和铁亲和力:改善铁的生物可用性和肠道微生物群调节的影响
Hao-Bin Lin1, Chun-Yan Peng1, Hui Wang2
1National R&D Center for Freshwater Fish Processing, College of Life Science & School of Health, Jiangxi Normal University, Nanchang, Jiangxi, China.
NPJ science of food
|November 26, 2025
概括
驴皮凝水解剂 (DH) 显示出对缺铁性贫血 (IDA) 的承诺. 胆固醇增强了铁的吸收,促进了红细胞的产生,改善了肠道健康,提供了一个潜在的新的食补充剂.
科学领域:
- 营养科学 营养科学
- 生物化学 生物化学
- 胃肠病学 胃肠病学
背景情况:
- 缺铁性贫血 (IDA) 是一种普遍存在的营养障碍.
- 目前的铁补充剂具有较低的生物可用性,并引起副作用.
- 来自食物的蛋白质水解剂为铁的输送提供了潜在的解决方案.
研究的目的:
- 评估驴皮凝水解剂 (DH) 在治疗IDA中的疗效.
- 评估DH对血液形成,铁平衡和抗氧化状态的影响.
- 在IAD大鼠模型中研究DH对肝损伤和肠道微生物群的影响.
主要方法:
- 一个IAD老鼠模型被用于测试DH-铁 (DH-Fe) 的食补充剂.
- 测量了血液学参数,铁含量,抗氧化酶 (SOD) 和氧.
- 分析了肝损伤标志物和肠道微生物群组成.
主要成果:
- DH-Fe表现出优越的铁结合和稳定性.
- 补充DH显著增加了血红蛋白 (44%) 和正常化血清费里丁.
- DH增强了抗氧化剂防御,改善了肝脏健康,并通过增加像Ruminococcus这样的有益细菌来调节肠道微生物群.
结论:
- 驴皮凝水解剂 (DH) 有效地改善了血液形成和铁稳定.
- DH作为一种功能性的食铁载体,具有增强的生物可用性.
- DH显示出作为一种新的食补充剂的潜力,用于管理缺铁性贫血及其相关并发症.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
185
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
185
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
481
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
481
Bioavailability Enhancement: Drug Solubility Enhancement
204
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
204
Protein Digestion
110.3K
Protein digestion begins in the stomach, where the highly acidic environment can easily disrupt protein structure by exposing the peptide bonds of polypeptide chains. After polypeptide chains are broken into individual amino acids by a series of digestive enzymes, the amino acids are transported to the liver via the bloodstream to produce energy.
110.3K
Bioavailability Enhancement: Drug Permeability Enhancement
176
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
176

